Suryanrayan Somanathan

Title: Innovations of Suryanrayan Somanathan in Cholesterol Reduction

Introduction

Suryanrayan Somanathan is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of cholesterol management. His innovative work focuses on developing modified human low-density lipoprotein receptor (hLDLR) variants that can effectively reduce cholesterol levels.

Latest Patents

Somanathan holds a patent for "LDLR variants and their use in compositions for reducing cholesterol levels." This patent describes a recombinant vector that includes an expression cassette comprising a modified hLDLR gene. The gene encodes a modified hLDLR that features specific amino acid substitutions, which enhance its functionality. The patent also outlines pharmaceutical compositions that utilize this vector for lowering cholesterol and treating familial hypercholesterolemia. He has 1 patent to his name.

Career Highlights

Suryanrayan Somanathan is affiliated with the University of Pennsylvania, where he conducts his research and development work. His career is marked by a commitment to advancing medical science through innovative solutions that address critical health issues.

Collaborations

Somanathan collaborates with notable colleagues in his field, including James M. Wilson and Daniel J. Rader. These partnerships enhance the impact of his research and contribute to the development of effective treatments for cholesterol-related conditions.

Conclusion

Suryanrayan Somanathan's work exemplifies the intersection of innovation and healthcare. His contributions to cholesterol management through patented technologies are paving the way for new therapeutic approaches.